Your session is about to expire
← Back to Search
Focused Ultrasound
Transcranial ExAblate for Essential Tremor
N/A
Waitlist Available
Research Sponsored by InSightec
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 years post treatment
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing a new treatment for essential tremor that is safe and effective.
Eligible Conditions
- Essential Tremor
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 5 years post treatment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 years post treatment
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Number of Device and Procedure Related Adverse Events.
Secondary study objectives
Clinical Rating Scale for Tremor (CRST Part A) Posture Score Change From Baseline
Clinical Rating Scale for Tremor Part C - Activities of Daily Living.
Quality of Life in Essential Tremor Total (QUEST)
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Transcranial ExAblateExperimental Treatment1 Intervention
Transcranial ExAblate
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Transcranial ExAblate
2015
N/A
~140
Find a Location
Who is running the clinical trial?
InSightecLead Sponsor
91 Previous Clinical Trials
3,731 Total Patients Enrolled
12 Trials studying Essential Tremor
1,018 Patients Enrolled for Essential Tremor
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger